RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 100 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,041 | +46.8% | 2,968 | +5.6% | 0.00% | +100.0% |
| Q2 2023 | $46,353 | +32.5% | 2,811 | -7.4% | 0.00% | +100.0% |
| Q1 2022 | $34,975 | -53.5% | 3,036 | -59.7% | 0.00% | 0.0% |
| Q4 2021 | $75,189 | -34.5% | 7,534 | -14.3% | 0.00% | -50.0% |
| Q3 2021 | $114,837 | -52.9% | 8,793 | -29.4% | 0.00% | -33.3% |
| Q2 2021 | $243,771 | +19.2% | 12,450 | +29.5% | 0.00% | 0.0% |
| Q1 2021 | $204,511 | -31.9% | 9,615 | -4.8% | 0.00% | -25.0% |
| Q4 2020 | $300,332 | +37.2% | 10,102 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $218,910 | -2.8% | 10,102 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $225,275 | +46.5% | 10,102 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $153,752 | -29.0% | 10,102 | +7.0% | 0.00% | -25.0% |
| Q4 2019 | $216,674 | +23.2% | 9,437 | +15.9% | 0.00% | +33.3% |
| Q3 2019 | $175,829 | +54.0% | 8,144 | +56.9% | 0.00% | +50.0% |
| Q2 2019 | $114,202 | -7.5% | 5,191 | +15.3% | 0.00% | 0.0% |
| Q1 2019 | $123,400 | -8.6% | 4,502 | -10.3% | 0.00% | -33.3% |
| Q4 2018 | $134,938 | +5.8% | 5,020 | +14.8% | 0.00% | +50.0% |
| Q3 2018 | $127,560 | -34.9% | 4,373 | -35.3% | 0.00% | -33.3% |
| Q4 2017 | $196,000 | – | 6,757 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
| Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
| RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
| Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
| Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
| Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
| Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
| Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
| EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |